UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000044838
Receipt No. R000051216
Scientific Title The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome.
Date of disclosure of the study information 2021/07/13
Last modified on 2021/08/11 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome.
Acronym The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome.
Scientific Title The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome.
Scientific Title:Acronym The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome.
Region
Japan

Condition
Condition Turner's syndrome
Classification by specialty
Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the safety and efficacy of oocyte cryopreservation for Tuner's girl.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The numbers of retrieved oocyte
Key secondary outcomes complication

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Turner syndrome has been demonstrated by chromosomal testing, there is hope for fertility preservation, and it is psychologically accepted.
Key exclusion criteria If the patients not have the consent of primary doctor, if the patients do not have the consent of herself or her family, or if it is judged that the patients cannot tolerate this treatment both physically and mentally.
Target sample size 2

Research contact person
Name of lead principal investigator
1st name Nao
Middle name
Last name Suzuki
Organization St. Marianna University School of Medicine
Division name Obstetrics and Gynecology
Zip code 216-8511
Address 2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa
TEL 044-977-8111
Email nao@marianna-u.ac.jp

Public contact
Name of contact person
1st name Seido
Middle name
Last name Takae
Organization St. Marianna University School of Medicine
Division name Obstetrics and Gynecology
Zip code 216-8511
Address 2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa
TEL 044-977-8111
Homepage URL
Email s2takae@marianna-u.ac.jp

Sponsor
Institute St. Marianna University School of Medicine
Institute
Department

Funding Source
Organization N/A
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization St. Marianna University School of Medicine
Address 2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa
Tel 044-977-8111
Email k-sienbu.mail@marianna-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 07 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2021 Year 07 Month 12 Day
Date of IRB
2021 Year 07 Month 10 Day
Anticipated trial start date
2021 Year 07 Month 14 Day
Last follow-up date
2031 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information After IRB permission, the clinical study has started on thin August.

Management information
Registered date
2021 Year 07 Month 12 Day
Last modified on
2021 Year 08 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051216